Principal Financial Group’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,234
Closed -$121K 2410
2024
Q1
$121K Sell
10,234
-1,295
-11% -$15.4K ﹤0.01% 2252
2023
Q4
$141K Buy
11,529
+185
+2% +$2.27K ﹤0.01% 2219
2023
Q3
$109K Buy
+11,344
New +$109K ﹤0.01% 2272